CN1413664A - Chinese medicine for treating gout - Google Patents
Chinese medicine for treating gout Download PDFInfo
- Publication number
- CN1413664A CN1413664A CN 02132411 CN02132411A CN1413664A CN 1413664 A CN1413664 A CN 1413664A CN 02132411 CN02132411 CN 02132411 CN 02132411 A CN02132411 A CN 02132411A CN 1413664 A CN1413664 A CN 1413664A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- gout
- cortex
- rhizoma atractylodis
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating gout is prepared from 7 Chinese-medicinal materials including large-leaf gentian root, ash bark, atractylodes rhizome, etc. Its advantages are sure curative effect and no toxic by-effect.
Description
Technical field:
The present invention relates to treat the medicine of gout, is to disclose a kind of Chinese medicine preparation for the treatment of gout furtherly, belongs to the technical field of pharmaceuticals of Chinese traditional treatment gout.
Background technology:
Existing in the market medicine only is confined to clear up intravital uric acid to the treatment of goat, the laboratory values of uric acid reducing, but do not remove this sick pathogenesis, so uncontrollable recurrence.Interim medicine comprises diclofenac, colchicine etc., and after taking for a long time, serious damage people's kidney belongs to the medicine of curing the symptoms, not the disease.
Summary of the invention:
The present invention discloses a kind of Chinese medicine preparation for the treatment of gout, removes the pathogenesis of gout, makes body no longer produce the situation of uric acid surplus, thus fundamentally control disease recurrence, the treatment gout.
The present invention is according to pathogenesis and the Therapeutic Principle of motherland's traditional Chinese medical science traditional theory to the gout disease, in conjunction with the modern medicine achievement, selected pure Chinese herbal medicine with functions such as removing damp-heat, activating blood circulation to dissipate blood stasis, dredge the meridian passage, make pharmaceutical preparation through science, be used to remove the pathogenesis of gout, make body no longer produce the situation of uric acid surplus.
Medicine of the present invention is the Chinese medicine preparation of being made by following component (by ratio of weight and the number of copies):
Herba Lycopodii 10～15, Radix Gentianae Macrophyllae 10～15, Radix Semiaquilegiae 10～15, Cortex Fraxini 8～10,
Rhizoma Atractylodis 8～15, Cortex cercis chinensis 10～15, Fructus Liquidambaris 8～10.
Preferred prescription of the present invention is:
Herba Lycopodii 10, Radix Gentianae Macrophyllae 10, Radix Semiaquilegiae 10, Cortex Fraxini 8, Rhizoma Atractylodis 12, Cortex cercis chinensis 12, Fructus Liquidambaris 8.
Concrete processing procedure of the present invention is as follows:
Said medicine is taken by weighing in proportion, be ground into the fine powder about 20 orders, incapsulate and get final product through ripening, sterilization.
Above-mentioned medicament can be a said dosage form on any pharmaceutics.
In the present invention, Herba Lycopodii, Radix Gentianae Macrophyllae, Radix Semiaquilegiae, Cortex Fraxini have function and the heat-clearing and toxic substances removing collaterals and relieving pain of draining uric acid, just are being suitable for goat and are showing as blood uric acid height, articular instability and the anxious symptom of sending out the phase red and swollen heat pain, so be principal agent with this four medicine; Because of the pathogenesis of goat mainly shows as the resistance of damp-stagnancy network, so use Rhizoma Atractylodis, the Cortex cercis chinensis wind-damp dispelling removes collateral dredging, and get Rhizoma Atractylodis the cold expelling that induces sweat meaning with separate gout fall ill at all; With depressed liver-energy dispersing and QI regulating, promoting the circulation of blood is promoted blood circulation to help the Rhizoma Atractylodis cold expelling with Fructus Liquidambaris.
Indication of the present invention comprises: gout, rheumatism, rheumatoid, Kaschin-Beck disease, renal failure.
Instructions of taking: 2 times/day, 5～8 grams/time.
Further specify curative effect of the present invention with regard to clinical effectiveness of the present invention below: goat is that long-term purine metabolism obstacle, blood uric acid increase the one group of disease that causes tissue injury.Primary disease belongs to categories such as the arthromyodynia, gout, severe and migratory arthralgia of the traditional Chinese medical science, be meant because of exopathogen retardance meridians, coagulation of QI-blood, the pain of joint muscle numbness that Liver and kidney two void cause, weighing, the disease of joint stuffiness, many, the tophuses stiff of chronic patient, nephropathy etc. with joint deformity.
Criterion:
Clinical recovery---symptom complete obiteration, joint function recovery is normal, and main physico-chemical examination index is normal.
Produce effects---cardinal symptom disappears, and function of joint is recovered substantially, and main physico-chemical examination index is normal substantially.
Effectively---cardinal symptom disappears substantially, and main function of joint and main physical and chemical index make moderate progress.
Invalid---with the treatment before compare, each side does not all have improvement.
Clinical statistics is used the T statistical theory and 30 routine patient with gout is treated 11 examples of fully recovering (37%), produce effects 9 examples (30%), effective 7 examples (23%), invalid 3 examples (10%).
Good effect of the present invention is: with pure Chinese herbal medicine is raw material, through science preparation, thereby fundamentally removes the pathogenesis of gout, and better controlled gout palindromia makes body no longer produce the situation of uric acid surplus, treatment gout.Curative effect is reliable, has no side effect.
The specific embodiment:
Embodiment 1
Take by weighing Herba Lycopodii 10g, Radix Gentianae Macrophyllae 10g, Radix Semiaquilegiae 10g, Cortex Fraxini 8g, Rhizoma Atractylodis 12g, Cortex cercis chinensis 12g, Fructus Liquidambaris 8g.Be ground into the fine powder about 20 orders, incapsulate and get final product.
Embodiment 2
Take by weighing Herba Lycopodii 10g, Radix Gentianae Macrophyllae 10g, Radix Semiaquilegiae 10g, Cortex Fraxini 8g, Rhizoma Atractylodis 12g, Cortex cercis chinensis 12g, Fructus Liquidambaris 8g, dividing and adding water three times is 8,6,6 times of amounts, decocted 2,1,1 hours, merge three times decocting liquid, filtrate is concentrated into the extractum shape that relative density is 1.20～1.25 (50 ℃), makes powdery powder.
Claims (3)
1, a kind of Chinese medicine preparation for the treatment of gout is characterized in that it being the preparation of being made by following medicine (by ratio of weight and the number of copies):
Herba Lycopodii 10～15, Radix Gentianae Macrophyllae 10～15, Radix Semiaquilegiae 10～15, Cortex Fraxini 8～10,
Rhizoma Atractylodis 8～15, Cortex cercis chinensis 10～15, Fructus Liquidambaris 8～10.
2, Chinese medicine preparation according to claim 1 is characterized in that optimum ratio is:
Herba Lycopodii 10, Radix Gentianae Macrophyllae 10, Radix Semiaquilegiae 10, Cortex Fraxini 8, Rhizoma Atractylodis 12, Cortex cercis chinensis 12, Fructus Liquidambaris 8.
3,, it is characterized in that said medicament is a said dosage form on any pharmaceutics according to claim 1,2 described Chinese medicine preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132411 CN1413664A (en) | 2002-06-05 | 2002-06-05 | Chinese medicine for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132411 CN1413664A (en) | 2002-06-05 | 2002-06-05 | Chinese medicine for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1413664A true CN1413664A (en) | 2003-04-30 |
Family
ID=4746754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02132411 Pending CN1413664A (en) | 2002-06-05 | 2002-06-05 | Chinese medicine for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1413664A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100457143C (en) * | 2004-11-29 | 2009-02-04 | 成都华西天然药物有限公司 | Medication for treating gout |
| CN100574781C (en) * | 2006-03-28 | 2009-12-30 | 通威股份有限公司 | A kind of veterinary drug for the treatment of gout and its production and use |
-
2002
- 2002-06-05 CN CN 02132411 patent/CN1413664A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100457143C (en) * | 2004-11-29 | 2009-02-04 | 成都华西天然药物有限公司 | Medication for treating gout |
| CN100574781C (en) * | 2006-03-28 | 2009-12-30 | 通威股份有限公司 | A kind of veterinary drug for the treatment of gout and its production and use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303A (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its prepn | |
| CN101919988B (en) | Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof | |
| CN1193775C (en) | Rheumatoid disease treating capsule | |
| CN103566236B (en) | A kind for the treatment of of arthritis and promoting collateral and channels Chinese medicine preparation | |
| CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
| CN1317021C (en) | Chinese medicinal formulation for stopping pain for removing Bi | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN1657067A (en) | Chinese medicine for treating psoriasis | |
| CN1059105C (en) | Bi Syndrome curing medicine | |
| CN100402065C (en) | Capsule for treating gout and preparation process thereof | |
| CN1907353A (en) | Chinese traditional medicine preparation for treating chronic gastritis | |
| CN1413664A (en) | Chinese medicine for treating gout | |
| CN102895572B (en) | Traditional Chinese medical composition for treatment of rheumatoid arthritis | |
| CN1911423A (en) | Decoction for treating sharp pain type rheumatoid arthritis, and its prepn. method | |
| CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof | |
| CN109432309A (en) | Chinese medicine composition, exterior-applied medical wine and its preparation method and application | |
| CN102512566A (en) | Chinese medicine composition for treating kidney deficiency and lumbago | |
| CN1342478A (en) | Medical wine for treating rheumatism | |
| CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
| CN106668787A (en) | Traditional Chinese medicine honeyed pill for treating hepatonecrosis and liver cancer and preparation method of traditional Chinese medicine honeyed pill | |
| CN1168473C (en) | Chinese medicine prepn for treating arterioscleriosis | |
| CN101361934B (en) | Traditional Chinese medicine preparation for treating arthritis and various osteonosus | |
| CN1168472C (en) | Chinese medicine prepn for treating lupus erythematosus | |
| CN1840146A (en) | Medicament for treating vitiligo | |
| CN105560737A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |